Screener
Vertex Pharmaceuticals VRTX Net Income
Net Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Vertex Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Vertex Pharmaceuticals’s 8-K, filed August 3, 2026. Open the filing →
- Filed
- Aug 3, 2026, 4:09 PM EDT
- Accession
- 0000875320-26-000256
FAQ
- What is Vertex Pharmaceuticals's net income?
- Vertex Pharmaceuticals (VRTX) reported net income of $1.1B in Q2 2026.
- How has Vertex Pharmaceuticals's net income changed year-over-year?
- Vertex Pharmaceuticals's net income increased by 6.5% year-over-year, from $1.03B to $1.1B.
- What is the long-term trend for Vertex Pharmaceuticals's net income?
- Over 3 years (2021 to 2025), Vertex Pharmaceuticals's net income has grown at a 19.1% compound annual growth rate (CAGR), from $2.34B to $3.95B.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Vertex Pharmaceuticals's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude